Anugraha Hospitals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 29-07-2024
- Paid Up Capital ₹ 2.32 Cr
as on 29-07-2024
- Company Age 24 Year, 2 Days
- Last Filing with ROC 31 Mar 2023
- Revenue 494.90%
(FY 2023)
- Profit 20.55%
(FY 2023)
- Ebitda -479.10%
(FY 2023)
- Net Worth -3.03%
(FY 2023)
- Total Assets 130.55%
(FY 2023)
About Anugraha Hospitals
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.32 Cr, as per Ministry of Corporate Affairs (MCA) records.
Parveen Hafeez and Padiyath Hafeez serve as directors at the Company.
- CIN/LLPIN
U85110KL2001PTC014457
- Company No.
014457
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Jan 2001
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Malappuram, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anugraha Hospitals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parveen Hafeez  | Director | 28-Feb-2010 | Current |
| Padiyath Hafeez | Director | 28-Feb-2010 | Current |
Financial Performance of Anugraha Hospitals.
Anugraha Hospitals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 494.9% increase. The company also saw a substantial improvement in profitability, with a 20.55% increase in profit. The company's net worth dipped by a decrease of 3.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anugraha Hospitals?
In 2023, Anugraha Hospitals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sunrise Institute Of Medical Sciences Private LimitedActive 22 years 2 monthsParveen Hafeez and Padiyath Hafeez are mutual person
Ortus Builders Private LimitedActive 10 years 7 monthsParveen Hafeez and Padiyath Hafeez are mutual person
- Boardwalk Hospitalities And Developers Private LimitedActive 14 years 10 months
Parveen Hafeez and Padiyath Hafeez are mutual person
- Iware Software Solutions Private LimitedActive 1 year 6 months
Parveen Hafeez and Padiyath Hafeez are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anugraha Hospitals?
Unlock and access historical data on people associated with Anugraha Hospitals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anugraha Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anugraha Hospitals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
